Table 3.
Dietary survey for DHA/EPA and placebo treatment groups.
| Variable | Baseline | Week 12 | ||||
|---|---|---|---|---|---|---|
| DHA/EPA Group (n = 33) | Placebo Group (n = 33) | p Value | DHA/EPA Group (n = 32) | Placebo Group (n = 32) | p Value | |
| Energy (kcal) | 2391.7 ± 714.6 | 2261.8 ± 459.5 | 0.383 | 2505.9 ± 745.9 | 2245.7 ± 453.4 | 0.143 |
| Protein (g) | 98.7 ± 35.1 | 95.6 ± 19.7 | 0.655 | 103.5 ± 34.1 | 95.3 ± 19.3 | 0.226 |
| Fat (g) | 86.2 ± 33.7 | 84.5 ± 22.2 | 0.811 | 90.8 ± 33.6 | 82.7 ± 20.3 | 0.165 |
| Carbohydrate (g) | 294.3 ± 77.4 | 268.5 ± 58.2 | 0.131 | 307.1 ± 90.4 | 269.2 ± 55.0 | 0.172 |
| Omega-3 fatty acid (g) | 2.6 ± 1.1 | 2.5 ± 0.6 | 0.831 | 2.7 ± 1.0 | 2.6 ± 0.7 | 0.545 |
| Eicosapentaenoic acid (mg) | 163.5 ± 97.2 | 150.9 ± 66.2 | 0.542 | 163.2 ± 94.3 | 164.1 ± 86.1 | 0.523 |
| Docosahexaenoic acid (mg) | 347.1 ± 180.9 | 337.1 ± 124.0 | 0.795 | 352.3 ± 175.7 | 357.9 ± 147.2 | 0.659 |